GLEEVEC
Live / Registered — Registered and renewed (as of 21 Jun 2023)
What this means for you
Registered since 14 Jan 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Jan 2023).
Record
- Serial number
- 78056665
- Registration number
- 2675047
- Mark type
- Word mark
- Filed
- 04 Apr 2001
- Published for opposition
- 22 Oct 2002
- Registered
- 14 Jan 2003
- Next maintenance due
- 14 Jan 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, for use in the field of oncology, namely, for the treatment of cancer
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 21 Jun 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 Jun 2023 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 21 Jun 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Nov 2022 — TEAS SECTION 8 & 9 RECEIVED
- 14 Jan 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Dec 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 08 Dec 2012 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 08 Dec 2012 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 08 Dec 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Nov 2012 — TEAS SECTION 8 & 9 RECEIVED
- 18 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Feb 2008 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 19 Feb 2008 — ASSIGNED TO PARALEGAL
- 14 Feb 2008 — TEAS SECTION 8 & 15 RECEIVED